Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
After an FDA inspection at an Indian manufacturing facility, Lupin turns off the light
Source – Lupin Lupin, a major generics company, has received a relatively mild rebuke from the US Food and Drug ...
How will Medicare be affected by the cost of Leqembi from Eisai and Biogen? Sen. Sanders is curious
Senator Bernie Sanders (I-Vt.) is increasing his pressure on the US Department of Health and Human Services (HHS) regarding the ...
Promising Phase III Results: OCREVUS (Ocrelizumab) Subcutaneous Injection Offers Convenient and Efficient Treatment for Multiple Sclerosis
Source – Roche On 13 July Roche announced positive results from the Phase III OCARINA II trial, which investigated the ...
Daratumumab in Multiple Myeloma: What You Need to Know
Multiple myeloma is a serious and incurable blood cancer that affects millions of people worldwide. But there is hope. A ...
Third Line Treatment For Multiple Myeloma: What You Need to Know
Multiple myeloma is a type of blood cancer that affects plasma cells, which are responsible for producing antibodies. When plasma ...
Second-line treatment of multiple myeloma: current choices and future prospects
This blog will discuss the second-line treatment of multiple myeloma, a blood cancer that affects antibody-producing plasma cells. Multiple myeloma ...
First-Line Treatment of Multiple Myeloma: What You Need to Know
Multiple myeloma is a type of blood cancer that affects plasma cells, which are responsible for producing antibodies. It is ...
Multiple Myeloma: What You Need to Know About This Rare Blood Cancer
Imagine having a type of white blood cell that is supposed to protect you from infections, but instead turns against ...
The Safety of THIO Sequenced With Cemiplimab in NSCLC Remains Promising
Source – MAIA Biotechnology Two patients with advanced non-small cell lung cancer (NSCLC) have not experienced disease progression for 12.2 ...
Avutometinib/Defactinib Phase III Confirmatory Study in LGSOC Completes Design
Source – Verastem Oncology The FDA and Verastem Oncology have finalized the design of a Phase III clinical trial to ...
In unresectable/metastatic urothelial carcinoma, upfront nivolumab/chemotherapy prolongs survival
Source –Bristol-Myers Squibb Nivolumab plus chemotherapy showed statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival ...
VPAS negotiations are prohibited by the UK High Court from taking place
The British Generic Manufacturers Association (BGMA) has been denied a seat at the negotiation table for the new Voluntary Scheme ...
BMS purchases the Prothena Alzheimer’s medication in a $2.2 billion transaction
Source: Prothena Bristol-Myers Squibb has taken an option on a tau protein-targeting antibody in early-stage clinical development from Prothena on ...
Sensorion Seeks Approval for Clinical Trial of OTOF-GT Gene Therapy Candidate in the UK
Source – Sensorion On July 10, Sensorion filed its first regulatory application to start human testing of OTOF-GT, a gene ...
Better receives FDA approval for its primary DTx medication
Source –Better Therapeutics On 10 July, Digital health company Better Therapeutics received FDA approval for its lead digital therapeutic (DTx), ...
Takeda withdraws its FDA application for a dengue vaccine due to data disagreements with the authority
Source: Takeda Takeda announced on 11 July that it is withdrawing its application for the dengue vaccine candidate, TAK-003, from ...
After 7 patient fatalities and 5 other serious adverse events, ADC suspends the Zynlonta research
Source – ADC Therapeutics ADC Therapeutics has halted enrollment in a Phase II combination trial for Zynlonta following the investigation ...
Moderna Files Two New Patent Lawsuits Against mRNA Competitors Pfizer and BioNTech
In the ongoing patent disputes surrounding COVID-19 vaccines, Moderna has expanded its legal battle against Pfizer and BioNTech by filing ...
IA Gemcitabine Provides Survival Benefit in Patients with Locally Advanced Pancreatic Cancer
Source – RenovoRx The interim results of the Phase III TIGeR-PaC study (NCT03257033) presented at the 2023 European Society of ...
Insufficient use of gene sequencing for lung cancer in Europe
A recent report highlights that while next-generation sequencing (NGS) has the potential to improve patient outcomes and save money for ...
Future NHS Award goes to an AI-based tool for heart disease
A digital tool created by NHS researchers to expedite the diagnosis of heart disease has been honored with the Future ...
GLP-1 medications from Novo Nordisk are being examined in Europe following reports suggest potential suicide risks
Following reports of two cases of suicidal thoughts and one case of self-harm among users in Iceland, the European Medicines ...
After extending its Pfizer collaboration, Samsung Biologics signs a $391M manufacturing agreement with Novartis
Shortly after finalizing two deals worth $897 million with Pfizer, Samsung Biologics has expanded its partnership with Novartis, adding hundreds ...
Roche’s Columvi (glofitamab) for patients with R/R diffuse large B-cell lymphoma has received approval from the European Commission
Source – Roche On 11 July 2023 Roche announced that the European Commission (EC) has given conditional approval for Columvi ...
Paxalisib With Radiation Receives Fast Track Designation from FDA for Brain Metastases
The FDA has granted fast track designation to the combination of paxalisib (GDC-0084) and radiation for the treatment of patients ...
Humira biosimilar to be made available by RxPreferred via Mark Cuban’s online pharmacy
Pharmacy benefits manager (PBM) RxPreferred has unveiled its plan to provide the Humira biosimilar Yusimry through Mark Cuban Cost Plus ...
Novavax’s Covid vaccine receives a unanimous EU approval
Source – Novavax Novavax received full Marketing Authorization (MA) from the European Commission for its COVID-19 vaccine, Nuvaxovid (NVX-CoV2373). This ...
FDA criticizes Intas and Ipca for manufacturing flaws at three Indian factories
Following a slowdown in FDA inspections in recent years due to the pandemic, inspections are now back in full swing, ...
New lawsuits from Novo Nordisk are filed against synthetic versions of Wegovy and Ozempic
Source – FDA The increasing demand for GLP-1 drugs, which can lead to significant weight loss, has resulted in unauthorized ...
Following a report of an inhaler leak, Cipla recalls six batches of the asthma medication albuterol
Source – Cipla On July 10 2023, Cipla, a pharmaceutical company that recently received a 23-page Form 483 filing from ...
